AP3M2
AP-3 complex subunit mu-2
Also known as: AP3M2_HUMAN, AP47B, CLA20
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P53677
- Gene
- AP3M2
- Ensembl
- ENSG00000070718
- Chromosome
- 8
- Canonical length
- 418 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes a subunit of the heterotetrameric adaptor-related protein comlex 3 (AP-3), which belongs to the adaptor complexes medium subunits family. The AP-3 complex plays a role in protein trafficking to lysosomes and specialized organelles. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Aug 2008]
Canonical amino-acid sequenceUniProt
418 residues, UniProt reviewed canonical sequence.
>P53677|AP3M2
1 MIHSLFLINS SGDIFLEKHW KSVVSRSVCD YFFEAQERAT EAENVPPVIP TPHHYLLSVY
61 RHKIFFVAVI QTEVPPLFVI EFLHRVVDTF QDYFGVCSEP VIKDNVVVVY EVLEEMLDNG
121 FPLATESNIL KELIKPPTIL RTVVNTITGS TNVGDQLPTG QLSVVPWRRT GVKYTNNEAY
181 FDVIEEIDAI IDKSGSTITA EIQGVIDACV KLTGMPDLTL SFMNPRLLDD VSFHPCVRFK
241 RWESERILSF IPPDGNFRLL SYHVSAQNLV AIPVYVKHNI SFRDSSSLGR FEITVGPKQT
301 MGKTIEGVTV TSQMPKGVLN MSLTPSQGTH TFDPVTKMLS WDVGKINPQK LPSLKGTMSL
361 QAGASKPDEN PTINLQFKIQ QLAISGLKVN RLDMYGEKYK PFKGIKYMTK AGKFQVRTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against AP3M2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 39 nTPM
Expression across tissuesHPA
Tissue
- retina: 39 nTPM
- cerebral cortex: 30 nTPM
- hypothalamus: 25 nTPM
- cerebellum: 22 nTPM
- testis: 22 nTPM
- parathyroid gland: 21 nTPM
Single-cell type
- late spermatids: 110 nCPM
- melanocytes: 104 nCPM
- t-cells: 89 nCPM
- differentiating spermatogonia: 82 nCPM
- early spermatids: 69 nCPM
- urothelial cells: 61 nCPM
Immune cell
- memory CD4 T-cell: 16 nTPM
- naive CD4 T-cell: 15 nTPM
- MAIT T-cell: 9.7 nTPM
- memory CD8 T-cell: 8.1 nTPM
- NK-cell: 7.7 nTPM
- gdT-cell: 7.5 nTPM
Brain region
- cerebral cortex: 52 nTPM
- hypothalamus: 50 nTPM
- basal ganglia: 49 nTPM
- pons: 44 nTPM
- thalamus: 40 nTPM
- midbrain: 40 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.11
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.39
- DepMap mean gene effect
- -0.18
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- anterograde axonal transport
- anterograde synaptic vesicle transport
- clathrin-coated vesicle cargo loading, AP-3-mediated
- endocytosis
- intracellular protein transport
- synaptic vesicle coating
- synaptic vesicle recycling
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Clathrin adaptor, mu subunit
- Longin-like domain superfamily
- Clathrin adaptor, mu subunit, conserved site
- AP complex, mu/sigma subunit
- Mu homology domain
- AP-2 complex subunit mu, C-terminal superfamily
- Adaptor complexes medium subunit
- Adaptor complexes medium subunit family
- Clathrin adaptor complex small chain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads AP3M2 as an antibody target. Whether an autoantibody or antibody against AP3M2 could matter depends on whether native AP3M2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
AP3M2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label AP3M2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...